Cross-Border Impact Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Pendulumpendulumlife.comFeb 2025 · $22M
Pendulum is a probiotic and prebiotic supplement company that develops clinically-tested products targeting gut health, metabolic function, and glucose control, including proprietary strains like live Akkermansia.
HealthtechWellness & Fitness
Co-investorsDCVC (Data Collective)Felicis VenturesLowercarbon CapitalSequoia CapitalTrue VenturesDecisive Point+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.